Alexion Pharmaceuticals will significantly expand its operations in Ireland by constructing the company's first ever biologics manufacturing facility outside the U.S. This $502.6 million, four-year project, which will be constructed at Alexion's College Park site in Blanchardstown, is expected to create approximately 200 additional full-time jobs on completion, bringing Alexion's total workforce in Ireland to almost 500.

Since entering Ireland in 2013, Alexion has invested $145.2 million in two facilities—a vial fill-finish facility in Athlone and a global supply chain facility at College Park. Phase I of the College Park facility, comprising Global Supply Chain HQ, laboratories, packaging and warehousing operations, is expected to be operational by yearend.